Thomas Stephan
Stock Analyst at Stifel
(4.23)
# 491
Out of 4,412 analysts
24
Total ratings
68.75%
Success rate
11.09%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALC Alcon | Maintains: Buy | $95 | $77.58 | +22.45% | 3 | Apr 22, 2024 | |
| GKOS Glaukos | Reiterates: Buy | $110 | $96.00 | +14.58% | 4 | Apr 3, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 | $45.96 | +8.79% | 7 | Apr 1, 2024 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $7 | $5.55 | +26.13% | 5 | Mar 8, 2024 | |
| RXST RxSight | Maintains: Buy | $54 → $64 | $52.13 | +22.77% | 3 | Feb 29, 2024 | |
| BLCO Bausch + Lomb | Initiates: Hold | $16 | $14.54 | +10.04% | 1 | Dec 12, 2023 | |
| IRIX IRIDEX | Downgrades: Hold | $5 → $3 | $2.85 | +5.26% | 1 | Aug 26, 2022 |
Alcon
Apr 22, 2024
Maintains: Buy
Price Target: $95
Current: $77.58
Upside: +22.45%
Glaukos
Apr 3, 2024
Reiterates: Buy
Price Target: $110
Current: $96.00
Upside: +14.58%
STAAR Surgical Company
Apr 1, 2024
Maintains: Buy
Price Target: $50
Current: $45.96
Upside: +8.79%
Sight Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $5.55
Upside: +26.13%
RxSight
Feb 29, 2024
Maintains: Buy
Price Target: $54 → $64
Current: $52.13
Upside: +22.77%
Bausch + Lomb
Dec 12, 2023
Initiates: Hold
Price Target: $16
Current: $14.54
Upside: +10.04%
IRIDEX
Aug 26, 2022
Downgrades: Hold
Price Target: $5 → $3
Current: $2.85
Upside: +5.26%